Multiple Sclerosis Discovery Forum

Inspiring Connections

Most Viewed Papers

Recommendations to improve imaging and analysis of brain lesion load and atrophy in longitudinal studies of multiple sclerosis.
MHC-mismatched mixed chimerism augments thymic regulatory T-cell production and prevents relapse of EAE in mice.
HLA-DRB1 does not have a role in clinical response to interferon-beta among Iranian multiple sclerosis patients.
Laquinimod, a once-daily oral drug in development for the treatment of relapsing-remitting multiple sclerosis.
Increased prevalence, incidence, and female predominance of multiple sclerosis in northern Japan.
An assay to quantify species-specific anti-JC virus antibody levels in MS patients.
CD14 is a key organizer of microglial responses to CNS infection and injury.
Protection of tregs, suppression of Th1 and th17 cells, and amelioration of experimental allergic encephalomyelitis by a physically-modified saline.
Disseminated cryptococcosis in a patient with multiple sclerosis treated with fingolimod.
Shared HLA Class II in Six Autoimmune Diseases in Latin America: A Meta-Analysis.
2-photon imaging of phagocyte-mediated T cell activation in the CNS.
Unmet education, psychological and peer support needs of people with multiple sclerosis.
The elusive biomarker for personalized medicine in multiple sclerosis: The search continues.
International Pediatric Multiple Sclerosis Study Group criteria for pediatric multiple sclerosis and immune-mediated central nervous system demyelinating disorders: revisions to the 2007 definitions.
Glutamate gene polymorphisms predict brain volumes in multiple sclerosis.
Mixed Panniculitis Secondary to Interferon beta-1a Therapy in a Woman With Multiple Sclerosis.
Theranostic implications of nanotechnology in multiple sclerosis: a future perspective.
Fine-Tuning S1P Therapeutics.
Acylated and unacylated ghrelin impair skeletal muscle atrophy in mice.
Low vitamin D and elevated immunoreactivity against Epstein-Barr virus before first clinical manifestation of multiple sclerosis.
The antibody response to Epstein-Barr virions is altered in multiple sclerosis.
A case of multiple sclerosis with pure, massive superficial demyelination.
Multiple Sclerosis Increases Fracture Risk: A Meta-Analysis.
New TYSABRI® analysis at AAN annual meeting shows improved walking speed in significant number of MS patients
CNS response to a second pro-inflammatory event depends on whether the primary demyelinating lesion is active or resolved.

Pages